Organigram Reports Third Quarter Fiscal 2020 Results

Net revenue of $18.0 million compared to $24.8 million in Q3 2019 Generated positive cash flow from operations of $8.5 million as a result of monetization and optimization of working capital and ended the quarter with cash and short-term investments of $44.8 million Subsequent to quarter-end, raised $17.9 million in gross proceeds to complete theContinue reading “Organigram Reports Third Quarter Fiscal 2020 Results”

Chemesis International Inc. Reports Q3 2020 Financial Statements

VANCOUVER, BC / ACCESSWIRE / June 2, 2020 / Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announced its financial results for the third quarter of 2020 ended March 31, 2020. Unless otherwise stated, all references to currency are in CDN dollars. Third Quarter 2020 Financial & Operational Highlights Revenues of $4,529,524 and gross profit marginContinue reading “Chemesis International Inc. Reports Q3 2020 Financial Statements”

Supreme Cannabis Announces Q3 2020 Financial Results

Realigned and rightsized operating model delivers immediate cost savings, reducing quarter-over-quarter operating expenses by 23% excluding restructuring charges Increased recreational sales revenue by 245% year-over-year, grew recreational sales volumes by 26% quarter-over-quarter and is accelerating revenue generation with over 30 SKUs in provinces across Canada, new product launches and an enhanced retail distribution model Maintains a strongContinue reading “Supreme Cannabis Announces Q3 2020 Financial Results”